Balance Sheet

Accounts Payables Accumulated Expenses Assets Cash & Current Investments Cash & Equivalents Common Equity Convertible Debt Current Assets Current Deferred Revenue Current Leases Current Taxes Dividends payables Finished Goods Goodwill Goodwill & Intangibles Intangibles Inventory Liabilities and Shareholders Equity Long-Term Deferred Tax Non-Current Assets Non-Current Debt Non-Current Deferred Tax Liability Non-Current Deferred Tax Liability Non-Current Deffered Revenue Operating Leases Other Accumulated Expenses Other Non-Current Assets Other Non-Current Liabilities Payables Prepaid Assets Property, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw Materials Receivables Receivables - Net Retained Earnings Shareholder's Equity Shares Outstanding Short term Debt Short-term Investments Total Current Liabilities Total Debt Total Liabilities Total Non-Current Liabilities Treasury Shares Treasury Shares Work In Process

Cash Flow Statement

Daily Values

Growth Metrics

Others

Lemaitre Vascular (LMAT) Convertible Debt (2024 - 2025)

Lemaitre Vascular (LMAT) has disclosed Convertible Debt for 2 consecutive years, with $168.6 million as the latest value for Q4 2025.

Quarterly Convertible Debt rose 0.52% to $168.6 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $168.6 million through Dec 2025, up 0.52% year-over-year, with the annual reading at $168.6 million for FY2025, 0.52% up from the prior year.
Convertible Debt for Q4 2025 was $168.6 million at Lemaitre Vascular, roughly flat from $168.4 million in the prior quarter.
The five-year high for Convertible Debt was $168.6 million in Q4 2025, with the low at $167.8 million in Q4 2024.